Short Communication: The Peripheral Cannabinoid CB

Patryk Remiszewski, Eberhard Schlicker, Emilia Grzęda, Jolanta Weresa, Marek Toczek, Barbara Malinowska

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patryk RemiszewskiDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-1346-2226

Eberhard SchlickerDepartment of Pharmacology and Toxicology, University of Bonn, 53127 Bonn, Germany.

Emilia GrzędaDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-8798-991X

Jolanta WeresaDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0003-2622-9391

Marek ToczekDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-5823-0269

Barbara MalinowskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland.

Funding

Medical University of Białystok B.SUB.25.334

6 · The paper itself

Abstract

Peripherally restricted ('second-generation') cannabinoid CB

Indexed as

Cannabinoid Receptor AntagonistsEndocannabinoidsPyrazolesReceptor, Cannabinoid, CB1AnimalsArachidonic AcidsBenzamidesBlood PressureCarbamatesDesoxycorticosterone AcetateHypertensionMaleMorpholinesRatsRats, Inbred SHRAM6545Arachidonic AcidsBenzamidesCannabinoid Receptor AntagonistsCarbamatescyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterDesoxycorticosterone AcetateEndocannabinoidsmethanandamideMorpholinesPyrazolesReceptor, Cannabinoid, CB1AM6545cannabinoid receptorsDOCA-saltendocannabinoidsmethanandamideURB597

Identifiers

PMID42196427

DOI10.3390/ijms27104449

PMCPMC13207549

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.